179 related articles for article (PubMed ID: 26779100)
1. The is and ought of the Ethics of Neuroenhancement: Mind the Gap.
Forlini C; Hall W
Front Psychol; 2015; 6():1998. PubMed ID: 26779100
[TBL] [Abstract][Full Text] [Related]
2. Bottom Up Ethics - Neuroenhancement in Education and Employment.
Bard I; Gaskell G; Allansdottir A; da Cunha RV; Eduard P; Hampel J; Hildt E; Hofmaier C; Kronberger N; Laursen S; Meijknecht A; Nordal S; Quintanilha A; Revuelta G; Saladié N; Sándor J; Santos JB; Seyringer S; Singh I; Somsen H; Toonders W; Torgersen H; Torre V; Varju M; Zwart H
Neuroethics; 2018; 11(3):309-322. PubMed ID: 30220937
[TBL] [Abstract][Full Text] [Related]
3. True and false concerns about neuroenhancement: a response to 'Neuroenhancers, addiction and research ethics', by D M Shaw.
Heinz A; Kipke R; Müller S; Wiesing U
J Med Ethics; 2014 Apr; 40(4):286-7. PubMed ID: 23468510
[TBL] [Abstract][Full Text] [Related]
4. The Complexity of Neuroenhancement and the Adoption of a Social Cognitive Perspective.
Zelli A; Lucidi F; Mallia L
Front Psychol; 2015; 6():1880. PubMed ID: 26648906
[TBL] [Abstract][Full Text] [Related]
5. Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications.
Graf WD; Nagel SK; Epstein LG; Miller G; Nass R; Larriviere D
Neurology; 2013 Mar; 80(13):1251-60. PubMed ID: 23486879
[TBL] [Abstract][Full Text] [Related]
6. How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence Hypotheses.
Schleim S; Quednow BB
Front Pharmacol; 2018; 9():3. PubMed ID: 29403383
[TBL] [Abstract][Full Text] [Related]
7. Cognitive neuroenhancement: false assumptions in the ethical debate.
Heinz A; Kipke R; Heimann H; Wiesing U
J Med Ethics; 2012 Jun; 38(6):372-5. PubMed ID: 22228818
[TBL] [Abstract][Full Text] [Related]
8. Neuroenhancement: State of the Art and Future Perspectives.
Marazziti D; Avella MT; Ivaldi T; Palermo S; Massa L; Vecchia AD; Basile L; Mucci F
Clin Neuropsychiatry; 2021 Jun; 18(3):137-169. PubMed ID: 34909030
[TBL] [Abstract][Full Text] [Related]
9. Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people.
Boot BP; Partridge B; Hall W
Neurocase; 2012 Jun; 18(3):181-4. PubMed ID: 22007842
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives.
Daubner J; Arshaad MI; Henseler C; Hescheler J; Ehninger D; Broich K; Rawashdeh O; Papazoglou A; Weiergräber M
Neural Plast; 2021; 2021():8823383. PubMed ID: 33519929
[TBL] [Abstract][Full Text] [Related]
11. Do pharmacists have a right to refuse to fill prescriptions for abortifacient drugs?
Weinstein BD
Law Med Health Care; 1992; 20(3):220-3. PubMed ID: 1434764
[TBL] [Abstract][Full Text] [Related]
12. [Options, limits and ethics of pharmacological neuroenhancement].
Normann C; Boldt J; Maio G; Berger M
Nervenarzt; 2010 Jan; 81(1):66-74. PubMed ID: 19851745
[TBL] [Abstract][Full Text] [Related]
13. On pharmacological neuroenhancement as part of the new neurorights' pioneering legislation in Chile: a perspective.
Cornejo-Plaza MI; Saracini C
Front Psychol; 2023; 14():1177720. PubMed ID: 37533709
[TBL] [Abstract][Full Text] [Related]
14. Caught between is and ought: The Moral Dissonance Model.
Te Brake H; Nauta B
Front Psychiatry; 2022; 13():906231. PubMed ID: 36620666
[TBL] [Abstract][Full Text] [Related]
15. Medical ethics research between theory and practice.
ten Have HA; Lelie A
Theor Med Bioeth; 1998 Jun; 19(3):263-76. PubMed ID: 9691788
[TBL] [Abstract][Full Text] [Related]
16. Neuroenhancers, addiction and research ethics.
Shaw DM
J Med Ethics; 2012 Oct; 38(10):605-8. PubMed ID: 22888151
[TBL] [Abstract][Full Text] [Related]
17. The ethics of neuroenhancement.
Chatterjee A
Handb Clin Neurol; 2013; 118():323-34. PubMed ID: 24182389
[TBL] [Abstract][Full Text] [Related]
18. Moral Expertise in the Clinic: Lessons Learned from Medicine and Science.
McClimans L; Slowther A
J Med Philos; 2016 Aug; 41(4):401-15. PubMed ID: 27302969
[TBL] [Abstract][Full Text] [Related]
19. "It Was Me on a Good Day": Exploring the Smart Drug Use Phenomenon in England.
Vargo EJ; Petróczi A
Front Psychol; 2016; 7():779. PubMed ID: 27303339
[TBL] [Abstract][Full Text] [Related]
20. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
